NXGL.US Nexgel Inc

Healthcare Health Care Equipment & Supplies USA Stocks
3.88 USD
Close of Nov 15, 2026
3.00 40.40
Market cap
USD 2.08M
P/E
-
P/B
0.43x
ROE
-184.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is NXGL.US undervalued?

Graham number

The Graham number of Nexgel Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nexgel Inc fundamental analysis

No fundamental analysis for Nexgel Inc yet.

Nexgel Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nexgel Inc

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impai…

Full company profile